WEBVTT
Kind: captions
Language: en

00:00:01.480 --> 00:00:08.560 

[Music]

00:00:08.560 --> 00:00:08.570 

00:00:08.570 --> 00:00:11.290 

commonly<00:00:09.570> known<00:00:09.719> as<00:00:09.960> inner<00:00:10.440> ear<00:00:10.769> infection

00:00:11.290 --> 00:00:11.300 
commonly known as inner ear infection

00:00:11.300 --> 00:00:14.150 
commonly known as inner ear infection
acute<00:00:12.300> otitis<00:00:12.420> media<00:00:12.870> is<00:00:13.320> a<00:00:13.349> serious<00:00:13.950> and

00:00:14.150 --> 00:00:14.160 
acute otitis media is a serious and

00:00:14.160 --> 00:00:15.860 
acute otitis media is a serious and
frequently<00:00:14.580> encountered<00:00:15.179> pediatric

00:00:15.860 --> 00:00:15.870 
frequently encountered pediatric

00:00:15.870 --> 00:00:19.490 
frequently encountered pediatric
condition<00:00:17.810> under<00:00:18.810> the<00:00:18.960> presence<00:00:19.380> of

00:00:19.490 --> 00:00:19.500 
condition under the presence of

00:00:19.500 --> 00:00:21.980 
condition under the presence of
colonizing<00:00:20.100> bacteria<00:00:20.880> in<00:00:21.029> the<00:00:21.150> narrow<00:00:21.420> spaces

00:00:21.980 --> 00:00:21.990 
colonizing bacteria in the narrow spaces

00:00:21.990 --> 00:00:24.679 
colonizing bacteria in the narrow spaces
of<00:00:22.140> the<00:00:22.199> middle<00:00:22.470> ear<00:00:23.150> effective<00:00:24.150> treatment<00:00:24.630> of

00:00:24.679 --> 00:00:24.689 
of the middle ear effective treatment of

00:00:24.689 --> 00:00:26.000 
of the middle ear effective treatment of
otitis<00:00:24.990> media<00:00:25.170> can<00:00:25.680> be<00:00:25.769> especially

00:00:26.000 --> 00:00:26.010 
otitis media can be especially

00:00:26.010 --> 00:00:29.990 
otitis media can be especially
challenging<00:00:27.680> otitis<00:00:28.680> media<00:00:29.000> typically

00:00:29.990 --> 00:00:30.000 
challenging otitis media typically

00:00:30.000 --> 00:00:31.669 
challenging otitis media typically
begins<00:00:30.390> at<00:00:30.630> the<00:00:30.750> base<00:00:30.960> of<00:00:30.990> the<00:00:31.380> eustachian

00:00:31.669 --> 00:00:31.679 
begins at the base of the eustachian

00:00:31.679 --> 00:00:34.610 
begins at the base of the eustachian
tube<00:00:32.160> where<00:00:32.850> bacterial<00:00:33.390> pathogens<00:00:34.110> entered

00:00:34.610 --> 00:00:34.620 
tube where bacterial pathogens entered

00:00:34.620 --> 00:00:37.370 
tube where bacterial pathogens entered
from<00:00:34.739> the<00:00:34.800> back<00:00:34.920> of<00:00:35.280> the<00:00:35.399> throat<00:00:36.380> common

00:00:37.370 --> 00:00:37.380 
from the back of the throat common

00:00:37.380 --> 00:00:39.500 
from the back of the throat common
pathogens<00:00:38.010> include<00:00:38.640> streptococcus

00:00:39.500 --> 00:00:39.510 
pathogens include streptococcus

00:00:39.510 --> 00:00:44.500 
pathogens include streptococcus
pneumoniae<00:00:39.989> and<00:00:40.399> hemolysis<00:00:41.399> influenza<00:00:42.090> as

00:00:44.500 --> 00:00:44.510 
pneumoniae and hemolysis influenza as

00:00:44.510 --> 00:00:47.660 
pneumoniae and hemolysis influenza as
the<00:00:45.510> escalating<00:00:46.230> infection<00:00:46.829> grows<00:00:47.190> it

00:00:47.660 --> 00:00:47.670 
the escalating infection grows it

00:00:47.670 --> 00:00:49.880 
the escalating infection grows it
travels<00:00:48.420> along<00:00:48.719> the<00:00:48.960> walls<00:00:49.230> of<00:00:49.530> the<00:00:49.649> tube

00:00:49.880 --> 00:00:49.890 
travels along the walls of the tube

00:00:49.890 --> 00:00:52.369 
travels along the walls of the tube
until<00:00:50.280> it<00:00:50.789> eventually<00:00:51.270> reaches<00:00:52.020> the<00:00:52.199> middle

00:00:52.369 --> 00:00:52.379 
until it eventually reaches the middle

00:00:52.379 --> 00:00:56.090 
until it eventually reaches the middle
ear<00:00:53.570> the<00:00:54.570> immune<00:00:54.899> system<00:00:55.320> reacts<00:00:55.829> to<00:00:55.980> the

00:00:56.090 --> 00:00:56.100 
ear the immune system reacts to the

00:00:56.100 --> 00:00:58.490 
ear the immune system reacts to the
invading<00:00:56.610> bacteria<00:00:56.820> by<00:00:57.420> mobilizing<00:00:57.960> mast

00:00:58.490 --> 00:00:58.500 
invading bacteria by mobilizing mast

00:00:58.500 --> 00:01:01.340 
invading bacteria by mobilizing mast
cells<00:00:58.859> neutrophils<00:00:59.850> and<00:01:00.120> other<00:01:00.719> first<00:01:01.109> line

00:01:01.340 --> 00:01:01.350 
cells neutrophils and other first line

00:01:01.350 --> 00:01:05.179 
cells neutrophils and other first line
of<00:01:01.379> defense<00:01:01.829> leukocytes<00:01:03.890> these<00:01:04.890> cells

00:01:05.179 --> 00:01:05.189 
of defense leukocytes these cells

00:01:05.189 --> 00:01:07.399 
of defense leukocytes these cells
promote<00:01:05.580> a<00:01:05.760> localized<00:01:06.479> inflammatory

00:01:07.399 --> 00:01:07.409 
promote a localized inflammatory

00:01:07.409 --> 00:01:11.000 
promote a localized inflammatory
response<00:01:09.320> inflammation<00:01:10.320> causes<00:01:10.830> the

00:01:11.000 --> 00:01:11.010 
response inflammation causes the

00:01:11.010 --> 00:01:12.800 
response inflammation causes the
delicate<00:01:11.460> tissues<00:01:11.939> of<00:01:12.150> the<00:01:12.180> inner<00:01:12.420> ear<00:01:12.780> to

00:01:12.800 --> 00:01:12.810 
delicate tissues of the inner ear to

00:01:12.810 --> 00:01:16.010 
delicate tissues of the inner ear to
swell<00:01:13.350> creating<00:01:14.310> a<00:01:14.400> warm<00:01:14.700> closed<00:01:15.270> space<00:01:15.720> an

00:01:16.010 --> 00:01:16.020 
swell creating a warm closed space an

00:01:16.020 --> 00:01:18.649 
swell creating a warm closed space an
ideal<00:01:16.740> environment<00:01:17.369> for<00:01:17.430> bacteria<00:01:17.670> to<00:01:18.210> hide

00:01:18.649 --> 00:01:18.659 
ideal environment for bacteria to hide

00:01:18.659 --> 00:01:22.609 
ideal environment for bacteria to hide
and<00:01:18.990> grow<00:01:20.270> fluid<00:01:21.270> discharged<00:01:21.960> from<00:01:22.170> inflamed

00:01:22.609 --> 00:01:22.619 
and grow fluid discharged from inflamed

00:01:22.619 --> 00:01:25.010 
and grow fluid discharged from inflamed
tissues<00:01:23.130> further<00:01:23.520> compromises<00:01:24.479> the<00:01:24.630> region

00:01:25.010 --> 00:01:25.020 
tissues further compromises the region

00:01:25.020 --> 00:01:27.950 
tissues further compromises the region
in<00:01:25.290> this<00:01:26.189> environment<00:01:26.580> the<00:01:27.240> infection<00:01:27.840> is

00:01:27.950 --> 00:01:27.960 
in this environment the infection is

00:01:27.960 --> 00:01:31.819 
in this environment the infection is
able<00:01:28.380> to<00:01:28.500> grow<00:01:28.799> virtually<00:01:29.549> uncontained<00:01:30.829> one

00:01:31.819 --> 00:01:31.829 
able to grow virtually uncontained one

00:01:31.829 --> 00:01:34.340 
able to grow virtually uncontained one
potentially<00:01:32.670> serious<00:01:33.140> complication<00:01:34.140> of

00:01:34.340 --> 00:01:34.350 
potentially serious complication of

00:01:34.350 --> 00:01:37.399 
potentially serious complication of
otitis<00:01:34.619> media<00:01:35.299> arises<00:01:36.299> from<00:01:36.540> fluid<00:01:37.020> pressure

00:01:37.399 --> 00:01:37.409 
otitis media arises from fluid pressure

00:01:37.409 --> 00:01:42.460 
otitis media arises from fluid pressure
that<00:01:37.740> builds<00:01:38.009> in<00:01:38.369> the<00:01:38.460> tympanic<00:01:39.030> cavity

00:01:42.460 --> 00:01:42.470 

00:01:42.470 --> 00:01:44.749 

therefore<00:01:43.470> one<00:01:43.829> of<00:01:43.979> the<00:01:44.130> first<00:01:44.430> treatment

00:01:44.749 --> 00:01:44.759 
therefore one of the first treatment

00:01:44.759 --> 00:01:46.580 
therefore one of the first treatment
challenges<00:01:45.600> is<00:01:45.810> to<00:01:45.990> relieve<00:01:46.320> pressure

00:01:46.580 --> 00:01:46.590 
challenges is to relieve pressure

00:01:46.590 --> 00:01:49.789 
challenges is to relieve pressure
against<00:01:47.250> the<00:01:47.310> tympanic<00:01:47.939> membrane<00:01:48.479> in<00:01:48.799> the

00:01:49.789 --> 00:01:49.799 
against the tympanic membrane in the

00:01:49.799 --> 00:01:51.980 
against the tympanic membrane in the
case<00:01:49.979> of<00:01:50.159> otitis<00:01:50.460> media<00:01:50.990> surgical

00:01:51.980 --> 00:01:51.990 
case of otitis media surgical

00:01:51.990 --> 00:01:54.679 
case of otitis media surgical
ventilation<00:01:52.710> Aaron<00:01:53.189> gotta<00:01:53.399> me<00:01:53.610> is<00:01:54.060> usually

00:01:54.679 --> 00:01:54.689 
ventilation Aaron gotta me is usually

00:01:54.689 --> 00:01:56.840 
ventilation Aaron gotta me is usually
inadequate<00:01:55.009> since<00:01:56.009> the<00:01:56.219> incision<00:01:56.700> will

00:01:56.840 --> 00:01:56.850 
inadequate since the incision will

00:01:56.850 --> 00:02:00.289 
inadequate since the incision will
quickly<00:01:57.119> heal<00:01:57.479> over<00:01:58.820> placement<00:01:59.820> of<00:01:59.880> a<00:01:59.969> temp<00:02:00.210> an

00:02:00.289 --> 00:02:00.299 
quickly heal over placement of a temp an

00:02:00.299 --> 00:02:02.690 
quickly heal over placement of a temp an
ostomy<00:02:00.689> tube<00:02:01.020> provides<00:02:01.740> for<00:02:02.009> continuous

00:02:02.690 --> 00:02:02.700 
ostomy tube provides for continuous

00:02:02.700 --> 00:02:03.740 
ostomy tube provides for continuous
drainage<00:02:03.060> to<00:02:03.450> help

00:02:03.740 --> 00:02:03.750 
drainage to help

00:02:03.750 --> 00:02:07.550 
drainage to help
the<00:02:04.110> membrane<00:02:04.620> from<00:02:04.830> being<00:02:05.100> damaged<00:02:06.560> while

00:02:07.550 --> 00:02:07.560 
the membrane from being damaged while

00:02:07.560 --> 00:02:09.950 
the membrane from being damaged while
drainage<00:02:08.039> may<00:02:08.369> help<00:02:08.670> protect<00:02:09.210> the<00:02:09.390> tympanic

00:02:09.950 --> 00:02:09.960 
drainage may help protect the tympanic

00:02:09.960 --> 00:02:11.660 
drainage may help protect the tympanic
membrane<00:02:10.410> from<00:02:10.679> damage<00:02:11.070> due<00:02:11.340> to<00:02:11.370> fluid

00:02:11.660 --> 00:02:11.670 
membrane from damage due to fluid

00:02:11.670 --> 00:02:14.120 
membrane from damage due to fluid
pressure<00:02:11.820> it<00:02:12.720> does<00:02:12.990> little<00:02:13.260> to<00:02:13.410> address<00:02:13.830> the

00:02:14.120 --> 00:02:14.130 
pressure it does little to address the

00:02:14.130 --> 00:02:17.020 
pressure it does little to address the
underlying<00:02:14.510> bacterial<00:02:15.510> infection

00:02:17.020 --> 00:02:17.030 
underlying bacterial infection

00:02:17.030 --> 00:02:20.090 
underlying bacterial infection
fortunately<00:02:18.030> the<00:02:18.480> timpanist<00:02:19.020> ob2<00:02:19.380> can<00:02:19.830> also

00:02:20.090 --> 00:02:20.100 
fortunately the timpanist ob2 can also

00:02:20.100 --> 00:02:22.190 
fortunately the timpanist ob2 can also
serve<00:02:20.580> as<00:02:20.610> a<00:02:20.820> portal<00:02:21.360> for<00:02:21.600> the<00:02:21.660> delivery<00:02:22.170> of

00:02:22.190 --> 00:02:22.200 
serve as a portal for the delivery of

00:02:22.200 --> 00:02:26.020 
serve as a portal for the delivery of
antibiotics<00:02:23.100> into<00:02:23.610> the<00:02:23.820> middle<00:02:24.060> ear<00:02:24.980> however

00:02:26.020 --> 00:02:26.030 
antibiotics into the middle ear however

00:02:26.030 --> 00:02:28.730 
antibiotics into the middle ear however
excessive<00:02:27.030> inflammation<00:02:27.360> in<00:02:28.110> the<00:02:28.230> middle<00:02:28.560> ear

00:02:28.730 --> 00:02:28.740 
excessive inflammation in the middle ear

00:02:28.740 --> 00:02:31.160 
excessive inflammation in the middle ear
space<00:02:28.770> blocks<00:02:29.640> the<00:02:29.970> antibiotic<00:02:30.780> solution

00:02:31.160 --> 00:02:31.170 
space blocks the antibiotic solution

00:02:31.170 --> 00:02:33.520 
space blocks the antibiotic solution
from<00:02:31.650> reaching<00:02:31.860> all<00:02:32.190> areas<00:02:32.670> of<00:02:32.820> infection

00:02:33.520 --> 00:02:33.530 
from reaching all areas of infection

00:02:33.530 --> 00:02:36.320 
from reaching all areas of infection
bacteria<00:02:34.530> continue<00:02:35.040> to<00:02:35.190> grow<00:02:35.459> in<00:02:35.640> protected

00:02:36.320 --> 00:02:36.330 
bacteria continue to grow in protected

00:02:36.330 --> 00:02:38.750 
bacteria continue to grow in protected
pockets<00:02:37.070> perpetuating<00:02:38.070> the<00:02:38.190> localized

00:02:38.750 --> 00:02:38.760 
pockets perpetuating the localized

00:02:38.760 --> 00:02:42.920 
pockets perpetuating the localized
inflammatory<00:02:39.570> response<00:02:40.050> in<00:02:41.720> order<00:02:42.720> to

00:02:42.920 --> 00:02:42.930 
inflammatory response in order to

00:02:42.930 --> 00:02:45.590 
inflammatory response in order to
optimize<00:02:43.500> localized<00:02:44.160> antibiotic<00:02:45.060> therapy<00:02:45.239> in

00:02:45.590 --> 00:02:45.600 
optimize localized antibiotic therapy in

00:02:45.600 --> 00:02:47.330 
optimize localized antibiotic therapy in
the<00:02:45.720> treatment<00:02:45.750> of<00:02:46.290> otitis<00:02:46.650> media<00:02:46.890> with

00:02:47.330 --> 00:02:47.340 
the treatment of otitis media with

00:02:47.340 --> 00:02:49.850 
the treatment of otitis media with
attempt<00:02:47.820> an<00:02:47.910> ostomy<00:02:48.239> tube<00:02:48.600> it<00:02:49.140> is<00:02:49.170> necessary

00:02:49.850 --> 00:02:49.860 
attempt an ostomy tube it is necessary

00:02:49.860 --> 00:02:52.280 
attempt an ostomy tube it is necessary
to<00:02:49.950> address<00:02:50.400> both<00:02:50.670> the<00:02:50.940> infection<00:02:51.540> and<00:02:51.720> the

00:02:52.280 --> 00:02:52.290 
to address both the infection and the

00:02:52.290 --> 00:02:55.430 
to address both the infection and the
inflammation<00:02:53.120> cipro<00:02:54.120> Dex<00:02:54.330> otic<00:02:54.750> is<00:02:54.930> a<00:02:55.020> major

00:02:55.430 --> 00:02:55.440 
inflammation cipro Dex otic is a major

00:02:55.440 --> 00:02:57.290 
inflammation cipro Dex otic is a major
advance<00:02:55.980> in<00:02:56.190> the<00:02:56.280> topical<00:02:56.760> treatment<00:02:57.209> of

00:02:57.290 --> 00:02:57.300 
advance in the topical treatment of

00:02:57.300 --> 00:02:58.400 
advance in the topical treatment of
otitis<00:02:57.630> media

00:02:58.400 --> 00:02:58.410 
otitis media

00:02:58.410 --> 00:03:01.240 
otitis media
this<00:02:59.040> combination<00:02:59.459> contains<00:03:00.270> an<00:03:00.450> effective

00:03:01.240 --> 00:03:01.250 
this combination contains an effective

00:03:01.250 --> 00:03:03.290 
this combination contains an effective
anti-inflammatory<00:03:02.250> agent<00:03:02.730> dexamethasone

00:03:03.290 --> 00:03:03.300 
anti-inflammatory agent dexamethasone

00:03:03.300 --> 00:03:06.040 
anti-inflammatory agent dexamethasone
and<00:03:04.080> a<00:03:04.530> powerful<00:03:04.980> second-generation

00:03:06.040 --> 00:03:06.050 
and a powerful second-generation

00:03:06.050 --> 00:03:08.710 
and a powerful second-generation
fluoroquinolone<00:03:07.050> antibiotic<00:03:07.700> ciprofloxacin

00:03:08.710 --> 00:03:08.720 
fluoroquinolone antibiotic ciprofloxacin

00:03:08.720 --> 00:03:12.289 
fluoroquinolone antibiotic ciprofloxacin
as<00:03:09.720> an<00:03:10.290> anti-inflammatory<00:03:11.030> activity<00:03:12.030> of<00:03:12.180> the

00:03:12.289 --> 00:03:12.299 
as an anti-inflammatory activity of the

00:03:12.299 --> 00:03:14.390 
as an anti-inflammatory activity of the
dexamethasone<00:03:12.769> contacts<00:03:13.769> the<00:03:13.980> middle<00:03:14.220> ear

00:03:14.390 --> 00:03:14.400 
dexamethasone contacts the middle ear

00:03:14.400 --> 00:03:17.509 
dexamethasone contacts the middle ear
tissue<00:03:14.730> it<00:03:15.540> reduces<00:03:16.170> swelling<00:03:16.350> and<00:03:16.890> fluid

00:03:17.509 --> 00:03:17.519 
tissue it reduces swelling and fluid

00:03:17.519 --> 00:03:19.130 
tissue it reduces swelling and fluid
production<00:03:18.060> throughout<00:03:18.420> the<00:03:18.600> middle<00:03:18.870> ear

00:03:19.130 --> 00:03:19.140 
production throughout the middle ear

00:03:19.140 --> 00:03:21.800 
production throughout the middle ear
with<00:03:19.920> less<00:03:20.190> swelling<00:03:20.580> and<00:03:20.910> fluid<00:03:21.330> the

00:03:21.800 --> 00:03:21.810 
with less swelling and fluid the

00:03:21.810 --> 00:03:24.530 
with less swelling and fluid the
ciprofloxacin<00:03:22.760> antibiotic<00:03:23.760> reaches<00:03:24.209> further

00:03:24.530 --> 00:03:24.540 
ciprofloxacin antibiotic reaches further

00:03:24.540 --> 00:03:26.960 
ciprofloxacin antibiotic reaches further
into<00:03:25.080> the<00:03:25.170> middle<00:03:25.440> ear<00:03:25.590> space<00:03:25.950> and<00:03:26.640> the

00:03:26.960 --> 00:03:26.970 
into the middle ear space and the

00:03:26.970 --> 00:03:29.150 
into the middle ear space and the
broad-spectrum<00:03:27.620> antibiotic<00:03:28.620> has<00:03:28.769> greater

00:03:29.150 --> 00:03:29.160 
broad-spectrum antibiotic has greater

00:03:29.160 --> 00:03:31.130 
broad-spectrum antibiotic has greater
effectiveness<00:03:29.760> in<00:03:30.180> eradicating<00:03:31.019> the

00:03:31.130 --> 00:03:31.140 
effectiveness in eradicating the

00:03:31.140 --> 00:03:34.220 
effectiveness in eradicating the
infection<00:03:31.709> by<00:03:32.400> combining<00:03:32.850> dexamethasone<00:03:33.390> a

00:03:34.220 --> 00:03:34.230 
infection by combining dexamethasone a

00:03:34.230 --> 00:03:35.930 
infection by combining dexamethasone a
highly<00:03:34.829> effective<00:03:35.160> topical

00:03:35.930 --> 00:03:35.940 
highly effective topical

00:03:35.940 --> 00:03:38.030 
highly effective topical
anti-inflammatory<00:03:36.620> agents<00:03:37.620> with

00:03:38.030 --> 00:03:38.040 
anti-inflammatory agents with

00:03:38.040 --> 00:03:40.900 
anti-inflammatory agents with
ciprofloxacin<00:03:38.489> a<00:03:39.390> powerful<00:03:40.200> broad-spectrum

00:03:40.900 --> 00:03:40.910 
ciprofloxacin a powerful broad-spectrum

00:03:40.910 --> 00:03:43.819 
ciprofloxacin a powerful broad-spectrum
antibiotic<00:03:41.910> super<00:03:42.570> Dex<00:03:42.750> otic<00:03:43.170> achieves

00:03:43.819 --> 00:03:43.829 
antibiotic super Dex otic achieves

00:03:43.829 --> 00:03:46.610 
antibiotic super Dex otic achieves
effective<00:03:44.489> localized<00:03:45.209> treatment<00:03:45.810> of<00:03:46.110> acute

00:03:46.610 --> 00:03:46.620 
effective localized treatment of acute

00:03:46.620 --> 00:03:49.030 
effective localized treatment of acute
otitis<00:03:46.920> media<00:03:47.370> with<00:03:47.820> temp<00:03:48.209> in<00:03:48.329> ostomy<00:03:48.750> to

00:03:49.030 --> 00:03:49.040 
otitis media with temp in ostomy to

00:03:49.040 --> 00:03:52.819 
otitis media with temp in ostomy to
dexamethasone<00:03:50.040> a<00:03:50.790> highly<00:03:51.630> effective<00:03:51.989> topical

00:03:52.819 --> 00:03:52.829 
dexamethasone a highly effective topical

00:03:52.829 --> 00:03:57.140 
dexamethasone a highly effective topical
anti-inflammatory<00:03:53.780> agents<00:03:55.250> ciprofloxacin<00:03:56.250> a

00:03:57.140 --> 00:03:57.150 
anti-inflammatory agents ciprofloxacin a

00:03:57.150 --> 00:04:01.970 
anti-inflammatory agents ciprofloxacin a
powerful<00:03:58.049> broad-spectrum<00:03:59.239> antibiotic<00:04:00.980> cipro

00:04:01.970 --> 00:04:01.980 
powerful broad-spectrum antibiotic cipro

00:04:01.980 --> 00:04:04.280 
powerful broad-spectrum antibiotic cipro
Dex<00:04:02.220> otic<00:04:02.549> is<00:04:02.810> contraindicated<00:04:03.810> in<00:04:04.049> patients

00:04:04.280 --> 00:04:04.290 
Dex otic is contraindicated in patients

00:04:04.290 --> 00:04:06.650 
Dex otic is contraindicated in patients
with<00:04:04.709> a<00:04:04.739> history<00:04:04.980> of<00:04:05.280> hypersensitivity<00:04:05.850> to

00:04:06.650 --> 00:04:06.660 
with a history of hypersensitivity to

00:04:06.660 --> 00:04:10.130 
with a history of hypersensitivity to
ciprofloxacin<00:04:07.079> or<00:04:07.920> other<00:04:08.280> quinolones<00:04:09.140> cipro

00:04:10.130 --> 00:04:10.140 
ciprofloxacin or other quinolones cipro

00:04:10.140 --> 00:04:12.320 
ciprofloxacin or other quinolones cipro
Dec<00:04:10.290> sodic<00:04:10.620> is<00:04:10.799> not<00:04:11.130> indicated<00:04:11.760> for<00:04:11.790> viral

00:04:12.320 --> 00:04:12.330 
Dec sodic is not indicated for viral

00:04:12.330 --> 00:04:14.570 
Dec sodic is not indicated for viral
infections<00:04:12.709> if<00:04:13.709> the<00:04:13.860> infection<00:04:14.190> is<00:04:14.370> not

00:04:14.570 --> 00:04:14.580 
infections if the infection is not

00:04:14.580 --> 00:04:17.160 
infections if the infection is not
improved<00:04:15.090> after<00:04:15.510> one<00:04:15.750> week<00:04:15.989> of<00:04:16.169> treatment

00:04:17.160 --> 00:04:17.170 
improved after one week of treatment

00:04:17.170 --> 00:04:18.750 
improved after one week of treatment
culture<00:04:17.470> should<00:04:17.740> be<00:04:17.800> obtained<00:04:18.370> to<00:04:18.550> guide

00:04:18.750 --> 00:04:18.760 
culture should be obtained to guide

00:04:18.760 --> 00:04:21.870 
culture should be obtained to guide
further<00:04:19.060> treatment<00:04:19.980> most<00:04:20.980> commonly<00:04:21.550> reported

00:04:21.870 --> 00:04:21.880 
further treatment most commonly reported

00:04:21.880 --> 00:04:24.420 
further treatment most commonly reported
adverse<00:04:22.240> reactions<00:04:23.140> in<00:04:23.320> clinical<00:04:23.770> trials<00:04:24.220> and

00:04:24.420 --> 00:04:24.430 
adverse reactions in clinical trials and

00:04:24.430 --> 00:04:26.840 
adverse reactions in clinical trials and
a<00:04:24.670> om<00:04:24.970> patients<00:04:25.540> with<00:04:25.690> temp<00:04:25.960> and<00:04:26.050> ostomy<00:04:26.470> tubes

00:04:26.840 --> 00:04:26.850 
a om patients with temp and ostomy tubes

00:04:26.850 --> 00:04:31.410 
a om patients with temp and ostomy tubes
hear<00:04:27.850> discomfort<00:04:28.390> 3%<00:04:29.110> ear<00:04:29.830> pain<00:04:30.240> 2.3<00:04:31.240> percent

00:04:31.410 --> 00:04:31.420 
hear discomfort 3% ear pain 2.3 percent

00:04:31.420 --> 00:04:36.870 
hear discomfort 3% ear pain 2.3 percent
ear<00:04:32.320> residue<00:04:32.860> 0.5%<00:04:34.170> irritability<00:04:35.250> 0.5%<00:04:36.250> and

00:04:36.870 --> 00:04:36.880 
ear residue 0.5% irritability 0.5% and

00:04:36.880 --> 00:04:41.010 
ear residue 0.5% irritability 0.5% and
taste<00:04:37.660> perversion<00:04:38.320> 0.5%

